<DOC>
	<DOCNO>NCT00729560</DOCNO>
	<brief_summary>Polycystic Ovary Syndrome ( PCOS ) major cause infertility United States . Many woman PCOS demonstrate insulin resistance compensatory hyperinsulinemia.This due intrinsic form insulin resistance unique PCOS , many case , acquire insulin resistance due obesity . The importance observation lie fact hyperinsulinemia appear play important pathogenetic role hyperandrogenism anovulation obese lean woman PCOS .</brief_summary>
	<brief_title>Effects Flutamide Insulin Glucose Metabolism Women With Polycystic Ovary Syndrome</brief_title>
	<detailed_description>Hyperinsulinemia stimulate ovarian production androgen , especially testosterone , PCOS . Therefore , theoretically possible testosterone increase urinary clearance D-chiro-inositol ( uCl ( DCI ) PCOS , serve explanation correlation uClDCI insulin sensitivity . While regard possibility unlikely , important test . To accomplish , assess obese ( Body Mass Index ( BMI ) &gt; 30 kg/m2 ) woman without PCOS baseline , 4 week androgen action blockade drug flutamide . Flutamide antiandrogen work block bind androgen androgen receptor . We determine pharmacologic blockade ) decrease renal clearance DCI , ii ) increase circulate concentration DCi , iii ) enhance insulin-stimulated release D-chiro-inositol-containing inositolphosphoglycan ( DCI-IPG ) mediator OGTT .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Flutamide</mesh_term>
	<mesh_term>Inositol phosphate glycan</mesh_term>
	<criteria>( 1 ) Obese ( BMI≥30 kg/m2 ) woman PCOS 1840 year age : ) oligomenorrhea ( 8 menstrual period annually ) , ii ) biochemical hyperandrogenemia ( elevated total free testosterone ) , iii ) normal thyroid function test serum prolactin , iv ) exclusion 21αhydroxylase deficiency fast 17αhydroxyprogesterone &lt; 200 ng/dl.48 , ( 2 ) acceptable health basis interview , medical history , physical examination , laboratory test ( complete blood chemistry ( CBC ) , complete metabolic panel ( CMP ) , urinalysis , serum BetaHuman Chorionic Gonadotropin ( BhCG ) ) . ( 3 ) Signed , witness informed consent . ( 4 ) Ability comply study requirement . ( 1 ) Diabetes mellitus fast glucose oral glucose tolerance test ( OGTT ) , clinically significant pulmonary , cardiac , renal , hepatic , neurologic , psychiatric , infectious , neoplastic malignant disease ( nonmelanoma skin cancer ) . ( 2 ) Current use oral contraceptive . ( 3 ) Documented suspected recent ( within one year ) history drug abuse alcoholism . ( 4 ) Ingestion investigational drug within two month prior study onset .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>PCOS</keyword>
</DOC>